You cannot select more than 25 topics Topics must start with a letter or number, can include dashes ('-') and can be up to 35 characters long.
JobMarketPaper/Paper/outline3.txt

43 lines
1.8 KiB
Plaintext

How do I begin work on stuff
- next step is causal story. key points include
- we are trying to separate strategic and operational concerns. (why is this a difficult problem?)
- we can't trust what we are told
- terminations could be due to safety, strategic, or operational concerns.
- explaining confounding between
- population/market and enrollment.
-population/market and market conditions.
- market conditions and enrollment.
- describe other confounders
- safety and effectiveness
- duration <--> enrollment/termination
- Condition
- Decision to procede with Phase III trial
- How do I handle this?
- Introduce Do-Calculus
- DAG model
- What do I need to control for, in some form or other?
CURRENTLY HERE:
- Introduce Data
- Clinical Trial Progression
- AACT gives us information on
- terminated/completed status
- compound-indication pairs
- MeSH/RxNorm links
- Snapshots
- Market Conditions
- can't directly measure alternate treatments/standards of care.
- Can get measures of USP - formulary alternatives
- Can get number of generics or brand names with same drug.
- Population Sizes
- IHME Global Burden of Disease dataset. Best measure of impact of a given disease category.
- DALY's
- How much data do I have?
- Econometric model
- for a given state, what is the probability it will terminate?
- more accurately for my dist-diff analysis: for a given state, what is the distribution of the probabilities it will terminate?
- basic bernoulli-logistic model, linear in parameters.
- What are the specific things I am looking at?
- number of competing treatments.
- delaying close of enrollment.